egilok 200 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
sotahexal 160 mg tabletta
sandoz hungária kft. - sotalol -
sotahexal 80 mg tabletta
sandoz hungária kft. - sotalol -
egilok xr 25 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 50 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 100 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
egilok xr 200 mg retard tabletta
egis gyógyszergyár zrt. - metoprolol -
sutent
pfizer limited - szunitinibbel - gastrointestinal stromal tumors; carcinoma, renal cell; neuroendocrine tumors - daganatellenes szerek - gastrointestinal stromal tumour (gist)sutent is indicated for the treatment of unresectable and/or metastatic malignant gastrointestinal stromal tumour (gist) in adults after failure of imatinib mesilate treatment due to resistance or intolerance. metastatic renal cell carcinoma (mrcc)sutent is indicated for the treatment of advanced/metastatic renal cell carcinoma (mrcc) in adults. pancreatic neuroendocrine tumours (pnet)sutent is indicated for the treatment of unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumours with disease progression in adults. experience with sutent as first-line treatment is limited (see section 5.
protopic
leo pharma a/s - takrolimusz - dermatitis, atopic - egyéb bőrgyógyászati készítmények - flare treatmentadults and adolescents (16 years of age and above)treatment of moderate to severe atopic dermatitis in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. children (two years of age and above)treatment of moderate to severe atopic dermatitis in children (two years of age and above) who failed to respond adequately to conventional therapies such as topical corticosteroids. maintenance treatmentmaintenance treatment of moderate to severe atopic dermatitis for the prevention of flares and the prolongation of flare-free intervals in patients experiencing a high frequency of disease exacerbations (i. előforduló négy vagy több alkalommal évente), akik már az első reakció, hogy legfeljebb hat héttel a kezelés naponta kétszer takrolimusz tartalmú (elváltozások tiszta, majdnem tiszta vagy enyhén érintett).
sunitinib teva 12,5 mg kemény kapszula
teva b.v. - szunitinibbel -